{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:57:22Z","timestamp":1793069842881,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.rbmo.2024.103891","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T12:27:25Z","timestamp":1708086445000},"page":"103891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["What reproductive follow-up for adolescent and young women after cancer? A review"],"prefix":"10.1016","volume":"49","author":[{"given":"C.","family":"Decanter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Elefant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Poirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Courbiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.rbmo.2024.103891_bib0001","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.ejca.2013.07.014","article-title":"Pretreatment anti-M\u00fcllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer","volume":"49","author":"Anderson","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rbmo.2024.103891_bib0002","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2017.10.001","article-title":"The utility of anti-M\u00fcllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer","volume":"87","author":"Anderson","year":"2017","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.rbmo.2024.103891_bib0003","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/humrep\/dey216","article-title":"The impact of cancer on subsequent chance of pregnancy: a population-based analysis","volume":"33","author":"Anderson","year":"2018","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.rbmo.2024.103891_bib0004","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S1470-2045(18)30500-X","article-title":"Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial","volume":"19","author":"Anderson","year":"2018","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.rbmo.2024.103891_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.rbmo.2024.103891_bib0006","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","article-title":"Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials","volume":"31","author":"Behringer","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.rbmo.2024.103891_bib0007","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1210\/jc.2018-02257","article-title":"Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan","volume":"104","author":"Cameron","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"10.1016\/j.rbmo.2024.103891_bib0008","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.ejca.2014.06.011","article-title":"A highly-sensitive anti-M\u00fcllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer","volume":"50","author":"Chai","year":"2014","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.rbmo.2024.103891_bib0009","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.fertnstert.2021.02.006","article-title":"Oocyte vitrification for fertility preservation for both medical and nonmedical reasons","volume":"115","author":"Cobo","year":"2021","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.rbmo.2024.103891_bib0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.rbmo.2011.12.012","article-title":"Accumulation of oocytes: a new strategy for managing low-responder patients","volume":"24","author":"Cobo","year":"2012","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"10.1016\/j.rbmo.2024.103891_bib0011","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.rbmo.2009.11.010","article-title":"Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results","volume":"20","author":"Decanter","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"10.1016\/j.rbmo.2024.103891_bib0012","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.fertnstert.2014.05.014","article-title":"Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimullerian hormone assay","volume":"102","author":"Decanter","year":"2014","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.rbmo.2024.103891_bib0013","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.rbmo.2018.02.004","article-title":"Different patterns of ovarian recovery after cancer treatment suggest various individual ovarian susceptibilities to chemotherapy","volume":"36","author":"Decanter","year":"2018","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"10.1016\/j.rbmo.2024.103891_bib0014","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/humrep\/deab189","article-title":"Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling","volume":"36","author":"Decanter","year":"2021","journal-title":"Hum Reprod"},{"issue":"29","key":"10.1016\/j.rbmo.2024.103891_bib0015","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1200\/JCO.21.00068","article-title":"Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)","volume":"39","author":"Demeestere","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.rbmo.2024.103891_bib0017","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2024.103891_bib0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejca.2017.03.035","article-title":"Prospective evaluation of serum anti-M\u00fcllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer","volume":"79","author":"Dezellus","year":"2017","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.rbmo.2024.103891_bib0019","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.fertnstert.2012.09.039","article-title":"Pretreatment antimullerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy","volume":"99","author":"Dillon","year":"2013","journal-title":"Fertil Steril"},{"issue":"15","key":"10.1016\/j.rbmo.2024.103891_bib0020","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1007\/s00432-023-05035-z","article-title":"Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma","volume":"149","author":"Drechsel","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.rbmo.2024.103891_bib0021","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/humupd\/dmad002","article-title":"Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review","volume":"29","author":"Drechsel","year":"2023","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2024.103891_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.18938","article-title":"Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study","author":"Entrop","year":"2023","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.rbmo.2024.103891_bib0023","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humrep\/deac249","article-title":"Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation","volume":"38","author":"Fraison","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rbmo.2024.103891_bib0024","doi-asserted-by":"crossref","DOI":"10.1089\/jayao.2018.0036","article-title":"Anazodo A Reproductive Outcomes After a Childhood and Adolescent Young Adult Cancer Diagnosis in Female Cancer Survivors: A Systematic Review and Meta-analysis","author":"Gerstl","year":"2018","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"1","key":"10.1016\/j.rbmo.2024.103891_bib0026","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.clbc.2017.06.016","article-title":"Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta-analysis","volume":"18","author":"Gerstl","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"10.1016\/j.rbmo.2024.103891_bib0025","first-page":"4451","article-title":"Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis","volume":"27","author":"Gerstl BSullivan","year":"2019","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.rbmo.2024.103891_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2012.08.008","article-title":"Low concentration of circulating antimullerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study","volume":"98","author":"Hagen","year":"2012","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.rbmo.2024.103891_bib0028","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rbmo.2015.12.008","article-title":"Anti-M\u00fcllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies","volume":"32","author":"Hamy","year":"2016","journal-title":"Reprod Biomed Online"},{"issue":"185","key":"10.1016\/j.rbmo.2024.103891_bib0029","doi-asserted-by":"crossref","first-page":"185ra62","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide triggers follicle activation and \"burnout\"; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.rbmo.2024.103891_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/molehr\/gar059","article-title":"Data-driven assessment of the human ovarian reserve","volume":"18","author":"Kelsey","year":"2012","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.rbmo.2024.103891_bib0031","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fonc.2019.00575","article-title":"Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-m\u00fcllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy","volume":"9","author":"Lambertini","year":"2019","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.rbmo.2024.103891_bib0032","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.rbmo.2021.04.020","article-title":"Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts","volume":"43","author":"Legrand","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"10.1016\/j.rbmo.2024.103891_bib0033","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.26403","article-title":"Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer","volume":"118","author":"Letourneau","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.rbmo.2024.103891_bib0034","first-page":"1915","article-title":"The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options","volume":"25","author":"Lewin","year":"2017","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.rbmo.2024.103891_bib0035","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/ijc.33933","article-title":"Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patients","volume":"150","author":"Mailliez","year":"2022","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.rbmo.2024.103891_bib0036","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/dem027","article-title":"Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury","volume":"22","author":"Meirow","year":"2007","journal-title":"Hum Reprod"},{"issue":"31","key":"10.1016\/j.rbmo.2024.103891_bib0037","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1200\/JCO.21.00357","article-title":"Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study","volume":"39","author":"\u00d8vlisen","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rbmo.2024.103891_bib0038","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-12-26","article-title":"Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review","volume":"12","author":"Peigne","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"10.1016\/j.rbmo.2024.103891_bib0039","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.rbmo.2017.06.005","article-title":"Influence of adjuvant chemotherapy on anti-M\u00fcllerian hormone in women below 35 years treated for early breast cancer","volume":"35","author":"Perdrix","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.rbmo.2024.103891_bib0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejca.2022.05.013","article-title":"What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines","volume":"173","author":"Rives","year":"2022","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.rbmo.2024.103891_bib0041","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/humupd\/dmu019","article-title":"Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents","volume":"20","author":"Roness","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"5","key":"10.1016\/j.rbmo.2024.103891_bib0042","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.fertnstert.2020.11.040","article-title":"Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss","volume":"115","author":"Shai","year":"2022","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.rbmo.2024.103891_bib0043","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum Reprod Update"},{"issue":"14","key":"10.1016\/j.rbmo.2024.103891_bib0044","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age","volume":"318","author":"Steiner","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.rbmo.2024.103891_bib0045","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/ijc.26045","article-title":"Pregnancy after adolescent and adult cancer: a population-based matched cohort study","volume":"129","author":"Stensheim","year":"2011","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.rbmo.2024.103891_bib0046","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1210\/clinem\/dgaa172","article-title":"Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH","volume":"105","author":"Su","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.rbmo.2024.103891_bib0050","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/humrep\/dev060","article-title":"Ovarian reserve after treatment with alkylating agents during childhood","volume":"30","author":"Thomas-Teinturier","year":"2015","journal-title":"Hum Reprod"},{"issue":"10334","key":"10.1016\/j.rbmo.2024.103891_bib0047","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(22)00460-3","article-title":"Long-term care for people treated for cancer during childhood and adolescence","volume":"399","author":"Tonorezos","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.rbmo.2024.103891_bib0048","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/humrep\/dev060","article-title":"Ovarian reserve after treatment with alkylating agents during childhood","volume":"30","author":"Vathaire","year":"2015","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.rbmo.2024.103891_bib0049","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/humrep\/deab035","article-title":"Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)","volume":"36","author":"van den Berg","year":"2021","journal-title":"Hum Reprod"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648324000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648324000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:22:57Z","timestamp":1762546977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648324000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1472648324000804"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2024.103891","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What reproductive follow-up for adolescent and young women after cancer? A review","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2024.103891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103891"}}